D.L.S.I. Logo

D.L.S.I.

HR and recruitment services for temp, fixed-term, and permanent roles across industries.

ALDLS | PA

Overview

Corporate Details

ISIN(s):
FR0010404368
LEI:
969500EJ1VXQBOHQR803
Country:
France
Address:
Avenue Eric Bousch, 57600 Forbach
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Groupe DLSI is a human resources and recruitment services company specializing in temporary staffing, fixed-term contracts (CDD), and permanent placements (CDI). The group operates through a network of approximately 70 employment agencies and several specialized brands, including DLSI Emploi, TERCIO-RH for the tertiary sector, and EMO DLSI for wood industry trades. It serves a diverse range of industries by providing recruitment solutions for businesses and career support for job seekers across technical, administrative, and industrial roles. The company's key metrics for 2023 included 220 permanent employees and revenue of €204.5 million.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-24 17:45
Earnings Release
Groupe DLSI - Chiffre d'affaires 3ème trimestre 2025
French 259.7 KB
2025-09-26 17:45
Earnings Release
Groupe DLSI - Résultat 1er semestre 2025
French 321.6 KB
2025-06-20 11:00
Notice of Dividend Amount
Groupe DLSI - Mise en paiement du dividende 2025
French 189.0 KB
2025-05-14 10:55
Pre-Annual General Meeting Information
Groupe DLSI - Avis réunion valant convocation AGO 19-06-2025
French 496.6 KB
2025-05-12 08:50
Pre-Annual General Meeting Information
Groupe DLSI - Avis réunion valant convocation AGO 19-06-2025
French 496.6 KB
2025-05-02 15:20
Capital/Financing Update
Groupe DLSI - Transfert contrat de liquidité auprès de PORTZAMPARC BNP PARIBAS …
French 301.5 KB
2025-04-28 11:30
Audit Report / Information
Groupe DLSI - Rapport sur les comptes consolidés 2024
French 1.1 MB
2025-04-28 11:30
Related Party Transaction
Groupe DLSI - Rapport spécial sur les conventions réglementées 2024
French 440.4 KB
2025-04-26 07:00
Earnings Release
Groupe DLSI - Chiffre d'affaires 1er trimestre 2025
French 285.8 KB
2025-04-25 17:45
Earnings Release
GROUPE DLSI - Chiffre d'affaires 1er trimestre 2025
French 285.8 KB
2025-03-28 07:00
Earnings Release
Groupe DLSI - Résultat 2024
French 292.9 KB
2025-03-27 17:45
Earnings Release
Groupe DLSI - Résultat 2024
French 292.9 KB
2025-02-15 07:00
Earnings Release
Groupe DLSI - Chiffre d'affaires 2024
French 288.3 KB
2025-02-14 17:45
Earnings Release
Groupe DLSI - Chiffre d'Affaires 2024
French 288.3 KB
2025-01-25 07:00
Board/Management Information
Groupe DLSI - Nouvelle composition du Conseil de Surveillance
French 290.1 KB

Automate Your Workflow. Get a real-time feed of all D.L.S.I. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for D.L.S.I.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for D.L.S.I. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
iBio, Inc. Logo
AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.
United States of America IBIO
Ibotta, Inc. Logo
A performance marketing platform offering cash-back rewards to consumers from CPG brands.
United States of America IBTA
ICON PLC Logo
Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.
United States of America ICLR
IDEAYA Biosciences, Inc. Logo
Clinical-stage firm developing precision cancer therapies via synthetic lethality.
United States of America IDYA
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
IMMERSION CORP Logo
Licenses patented haptic feedback technology for mobile, gaming, and automotive interfaces.
United States of America IMMR
IMMUNIC, INC. Logo
Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America IMUX
IMMUTEP Ltd Logo
Developing LAG-3-based immunotherapies for cancer and autoimmune diseases.
United States of America IMMP

Talk to a Data Expert

Have a question? We'll get back to you promptly.